ESC Clinical Practice Guidelines on Cardio-Oncology:

out during cancer treatment and in the first year after treatment. Commonly Asked Questions Before Cancer Treatment Remember, you can ask your medical team if there is anything you would like to discuss, but here are some common questions that patients with cancer may have: Am I at risk for developing cardiovascular toxicity during cancer therapy? The risk for developing cardiovascular toxicity depends on three main factors: • Your heart health before cancer treatment starts You may have a healthy heart or you may have a heart problem already. The ESC Guidelines provide risk assessment tools that your medical team will use to understand your risk of cardiotoxicity before you start cancer treatment. • The heart risk of the cancer treatment you are going to receive Treatments for cancer work differently and have varying risks for causing cardiotoxicity. The cancer team will discuss these risks with you and decide which treatment is most appropriate. • How your heart health changes while you receive cancer treatment It is important that any signs of cardiotoxicity are found early to reduce the chances of them developing into serious complications. If you are at risk, a personal monitoring plan will be put together so
